clinical study of Nagabala Arjunadi Yoga in the management of Post Myocardial Infarction( Hridroga)

Phase 3

Conditions: Health Condition 1: I22- Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarctionHealth Condition 2: I229- Subsequent ST elevation (STEMI) myocardial infarction of unspecified site

Registration Number: CTRI/2021/03/032088

Lead Sponsor: Institute of Teaching and Research in Ayurveda Institute of National Importance Ministry of Ayush

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot Yet Recruiting

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

1. Patients diagnosed as having recent Myocardial Infarction, after 2 weeks of occurrence of the event upto 6 months of the event and under the standard conventional treatment will only be recruited into the present study.

2. Patients within the age limit of 30-65 years of either sex

3. Patients willing to sign the consent

Exclusion Criteria

Acute MI due to non â?? atheromatous causes

2. AMI associated with any other heart disease like valvular heart disease or congenital

heart disease

3. Patients with ejection fraction less than 35%

4. Patients with Recurrent MI

5. Pateints who had underwent Coronary artery bypass grafting

6. Post MI (within 2 weeks) or Unstable Angina

7. Patients with severe or uncontrolled Liver or Kidney disorders or malignant

hypertension or COPD patients

8. Patients with severe / serious arrhythmias or presenting with congestive cardiac failure

or ascitis

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
It is expected that the trial drug will improve the Post â?? MI ischemic outcome of the patient <br/ ><br>in terms of fatigue, angina severity and frequency, dyspnoea, functional capacity and LV <br/ ><br>functionTimepoint: 2 months

Secondary Outcome Measures